Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference To Be Webcast

 Thoratec Presentation At Bank Of America Merrill Lynch Healthcare Conference
                                To Be Webcast

PR Newswire

PLEASANTON, Cailf., April 30, 2014

PLEASANTON, Cailf., April 30, 2014 /PRNewswire/ -- Thoratec Corporation
(NASDAQ: THOR), a world leader in device-based mechanical circulatory support
therapies to save, support and restore failing hearts, said today it will be
participating in the Bank of America Merrill Lynch 2014 Healthcare Conference
on Tuesday, May 13.

Gary F. Burbach, President and Chief Executive Officer, will provide an update
on the company, beginning at 3:00 p.m., Pacific Daylight Time (6:00 p.m.,
Eastern Daylight Time).

The presentation will be available through the conference web site at
http://www.veracast.com/webcasts/baml/healthcare2014/id48110432503.cfm, or on
the company's web site at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart
failure. The company's products include the HeartMate® LVAS (Left Ventricular
Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than
20,000 devices implanted in patients suffering from heart failure. Thoratec
also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product
lines. Thoratec is headquartered in Pleasanton, California. For more
information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered
trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec
Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC,
and PediVAS is a registered trademark of Thoratec Switzerland GmbH.

SOURCE Thoratec Corporation

Website: http://www.thoratec.com
Contact: Neil Meyer, Director of Investor Relations, Thoratec Corporation,
(925) 738-0029
 
Press spacebar to pause and continue. Press esc to stop.